In this respect, it has been shown that while stroke inhibits the expression of EAAT2, Adrβ-blocker attenuates this inhibition [48]), suggesting that adrenergic receptors have a role in the expression of EAAT2, corroborating our results. The gene discussed is SLC1A2; the disease is stroke disorder.